- Report
- April 2024
- 185 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Report
- January 2024
- 144 Pages
Global
From €4084EUR$4,250USD£3,491GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,177GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,177GBP
- Report
- March 2024
- 183 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- March 2024
- 150 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- April 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- November 2023
- 139 Pages
Global
From €3060EUR$3,185USD£2,616GBP
€4372EUR$4,550USD£3,738GBP
- Report
- January 2024
- 180 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- January 2024
- 395 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,232GBP
- Report
- January 2024
- 141 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- April 2024
- 115 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- June 2023
- 104 Pages
Global
From €4276EUR$4,450USD£3,656GBP
- Report
- March 2018
- 220 Pages
Global
From €2114EUR$2,200USD£1,807GBP
- Report
- March 2023
- 130 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- August 2022
- 117 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- March 2023
- 203 Pages
Global
From €3459EUR$3,600USD£2,957GBP
- Report
- March 2023
- 74 Pages
North America
From €1441EUR$1,500USD£1,232GBP
- Report
- March 2023
- 84 Pages
Middle East, Africa
From €1441EUR$1,500USD£1,232GBP
Gabapentin is a medication used to treat certain types of seizures and nerve pain. It is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to produce its effects. It is used to treat epilepsy, neuropathic pain, hot flashes, and restless leg syndrome. It is also used off-label to treat anxiety and insomnia. Gabapentin is generally well-tolerated, but can cause side effects such as dizziness, drowsiness, and confusion.
Gabapentin is available in both generic and brand-name forms. It is available in capsule, tablet, and oral solution forms. It is also available as an extended-release tablet, which is taken once daily.
The market for Gabapentin is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the companies in the market include Pfizer, Mylan, Teva Pharmaceuticals, Sun Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more